Interesting 'conversation' with CLL experts on a variety of topics including:
Do patients with CLL have worse outcomes if they develop COVID‑19?
Are data available on COVID-19 outcomes in younger patients with CLL?
Would it be possible for CLL-associated lymphocytosis to counteract COVID-19–associated lymphopenia in patients with CLL who are not receiving treatment?
Minimizing Risk and Treating COVID-19 in Patients With CLL
Are patients with CLL at greater risk for becoming infected with SARS-CoV-2?
Selecting Treatment for CLL in the COVID-19 Era
When would you hold therapy in a patient with CLL who has asymptomatic COVID‑19
Clinical Considerations Surrounding BTK Inhibition and COVID-19 in Patients With CLL
Implications of COVID-19 Vaccination in Patients With CLL
Answers and much more here: clinicaloptions.com/infecti...